UnitedHealth Group has had a difficult year marked by a dramatic stock drop, leadership shake-up and mounting regulatory ...

Messenger RNA technology offers a faster way to develop vaccines to address or prepare for pandemics, and Moderna’s vaccine ...

Acquiring FarmboxRx will help Pyx Health tackle food insecurity, a challenge many of its members struggle with.

The current prior authorization process in U.S. healthcare constitutes a crisis, according to Jesse Ehrenfeld, immediate past ...

In calling for more clinical testing of vaccines in younger people and those who face a low risk of severe disease from Covid ...

The bottom line is that while recognizing there is an issue is vital, too many healthcare organizations are counting on solutions that cannot and will not provide a sufficient line of defense.

Healthcare and benefits leaders must step up to provide menopausal women with the full-spectrum care they need to protect ...

Social determinants of health (SDOH) screening tools have been prioritized in emerging healthcare delivery models aimed at transforming traditional care delivery and reimbursing a broader bench of ...

Healthcare costs are a top concern across the United States, with 2025 anticipated to be the most expensive year for employer-sponsored insurance yet. Employers are expected to face an 8 to 9% ...

Every minute matters in healthcare. Outdated systems and disjointed workflows can stall the flow of critical clinical information. Today’s providers often face the challenge of retrieving vital ...

This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive. Health tech companies made several major funding announcements in May.

Akero Therapeutics’ preliminary Phase 2b data show that treatment with its MASH drug, efruxifermin, continued to distance itself from a placebo measured at nearly two years of treatment.